(Date:11/21/2008)...to work together to stop abusive behavior, experts...) -- Behavior that was once dismissed as "kids bei...s mounting research shows the negative effects on ...ssionals, schools, parents and even kids themselve...tening behavior. , "Bullying shouldn,t be cons...
(Date:11/21/2008)...swire-USNewswire/ -- During a memorial service in...today remembered Lieutenant Governor Catherine Bak...er in public service, and a tireless advocate for ...st woman elected lieutenant governor, Catherine wa...or Rendell. "Her family and her faith were driving...
(Date:11/21/2008)... about future antibiotic resistance from widesprea...ews) -- People with moderate to severe chronic obs...educe the frequency of exacerbations through a reg...t says. , The study, published in the first is...ratory and Critical Care Medicine , found that twi...
(Date:11/21/2008)...ewswire-USNewswire/ -- New research at West Virgi...spitless tobacco product aimed at young adults is ...J Reynolds, Camel Snus - touted as a socially acce...ingly high levels of nicotine. , , "Camel S...roducts," said Bruce Adkins of the state Division ...
Breaking Medicine News(10 mins):Health News:Getting Tough on Bullying 2Health News:Getting Tough on Bullying 3Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3Health News:Long-Term Erythromycin Cut COPD Complications 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3(Date:11/20/2008)...Nov. 20 Milk. It does a body good....y thought. After years of,research, scientists at...in,cow,s milk that stimulate the body,s own produ...ltimedia News Release, go to:, http://www.prnewswi...developing new cancer therapies, the chief scienti...
(Date:11/20/2008)...ov. 20 Duska Therapeutic...day that it has submitted its,pivotal Phase 3 ATP...cial,Protocol Assessment (SPA) procedure with the... Subject to securing an agreement with the FDA, D...ouble-blind, placebo-controlled and randomized Pha...
(Date:11/20/2008)...PRNewswire/ -- Clinical data from a prospective,r...th Symposium shows DVT,treatment with the Trellis...lar, Inc. (Santa Clara, CA) successfully breaks up...tes. , This technique, called isolated phar...more quickly and safely than current catheter-dire...
(Date:11/20/2008)... November 20 The Scandinavian-base...nounced results of studies on its,lead antimicrob...ngton, DC,the studies showed that the novel lyti... effect, significantly better towards killing Stap... marketed gold standard drugs. In,addition to thi...
Breaking Medicine Technology:Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2MedQuist and Clario Form Partnership to Integrate zVision Radiology Practice Management Software with SpeechQ for Radiology 29761 1MedQuist and Clario Form Partnership to Integrate zVision Radiology Practice Management Software with SpeechQ for Radiology 29761 2MedQuist and Clario Form Partnership to Integrate zVision Radiology Practice Management Software with SpeechQ for Radiology 29761 3Cystic Fibrosis Foundation Establishes Landmark Patient Assistance Foundation 29757 1Cystic Fibrosis Foundation Establishes Landmark Patient Assistance Foundation 29757 2Recognized Dermatology Expert Dr Zoe Draelos Joins Histogen Scientific Advisory Board 9185 1Recognized Dermatology Expert Dr Zoe Draelos Joins Histogen Scientific Advisory Board 9185 2Recognized Dermatology Expert Dr Zoe Draelos Joins Histogen Scientific Advisory Board 9185 3Voler Expands Medical Device Design Capabilities 9181 1Voler Expands Medical Device Design Capabilities 9181 2Voler Expands Medical Device Design Capabilities 9181 3...ivery System, NYON, Switzerland, March 29, 2007 /P...nced today that the Company,s HIV vaccine,elicited...el.,Mucosal IgA antibodies are considered a possib... The data were presented by,Sylvain Fleury, Ph.D.,...sentation, "Without Mucosal Adjuvant, Virosomes-gp...
...Call/ -- ADVENTRX,Pharmaceuticals, Inc. , a biop...ocused on commercializing proprietary product,ca...s diseases,announced today that results from pr...mbination with intravenous 5-fluorouracil (5-FU),...5-FU, will be,presented at the American Associat...
Other Medicine Technology:Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting,Protective Antibody Response in Mucosal Tissues of Non-Human,Primate Model 2Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting,Protective Antibody Response in Mucosal Tissues of Non-Human,Primate Model 3Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting,Protective Antibody Response in Mucosal Tissues of Non-Human,Primate Model 4ADVENTRX to Present CoFactor Multiagent Therapy Data at AACR Annual,Meeting 2ADVENTRX to Present CoFactor Multiagent Therapy Data at AACR Annual,Meeting 3For the determination of urea nitrogen in human serum.
Intended for the quantitative determination of urea nitrogen in serum. Reaction: kinetic, lag phase of less than 120 seconds, followed by linear phase of at least 240 seconds. Wavelength: 340 nm. Lin
Intended for the quantitative determination of urea nitrogen in serum. Reaction: kinetic. Wavelength: 340 nm. Linearity: 150 mg/dL (53.4 mmol/L urea) at 37C.
For the quantitative determination of direct bilirubin in human serum. Linearity: 20 mg/dl
Medicine Products: